Deutsche Bank AG Invests $1.12 Million in U.S. Physical Therapy, Inc. $USPH

Deutsche Bank AG bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,291 shares of the company's stock, valued at approximately $1,119,000. Deutsche Bank AG owned 0.11% of U.S. Physical Therapy as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the company. Rice Hall James & Associates LLC acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $1,279,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in U.S. Physical Therapy during the second quarter worth approximately $30,000. Simplicity Wealth LLC bought a new stake in U.S. Physical Therapy in the second quarter worth approximately $576,000. Bank of New York Mellon Corp bought a new stake in U.S. Physical Therapy in the second quarter worth approximately $9,087,000. Finally, City Center Advisors LLC acquired a new position in U.S. Physical Therapy in the second quarter valued at approximately $283,000.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $78.61 on Monday. The firm has a 50-day moving average of $74.97 and a 200-day moving average of $73.63. The company has a market cap of $1.17 billion, a P/E ratio of 462.44, a P/E/G ratio of 2.16 and a beta of 1.13. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. U.S. Physical Therapy, Inc. has a one year low of $58.19 and a one year high of $93.50.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.75 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The firm had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. During the same period in the previous year, the company posted $0.81 earnings per share. The company's revenue for the quarter was up 8.5% on a year-over-year basis. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.95 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy's payout ratio is presently 1,082.35%.

Insider Activity at U.S. Physical Therapy

In related news, Director Peter Francis Minan purchased 492 shares of the business's stock in a transaction that occurred on Monday, June 8th. The shares were bought at an average cost of $63.14 per share, with a total value of $31,064.88. Following the acquisition, the director owned 2,923 shares of the company's stock, valued at $184,558.22. This represents a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.40% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Citigroup reiterated a "market outperform" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Weiss Ratings reiterated a "hold (c-)" rating on shares of U.S. Physical Therapy in a report on Wednesday. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Citizens Jmp restated a "market outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Finally, Zacks Research raised U.S. Physical Therapy from a "strong sell" rating to a "hold" rating in a research report on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $99.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc NYSE: USPH is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source